Skip to content

NELSON LABS

Active
Private limited companyfounded 199035 yrs activeRomeinse straat 12, 3001 Leuven, BelgiumKBO/BCE: BE 0442.395.719
Summary

NELSON LABS has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €595.32M and a net result of €38.07M. Equity is growing by ~37% per year across the filed fiscal years. Its solvency ranks better than 72% of 190 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
76 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability61▼-8
Solvency100=
Growth73=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity short (current ratio 0.6 against 0.95 in 2024; short-term debt: 22.5% and cash: 3.6% of total assets), and 22.6% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
77.4%
Return on assets
5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 35 years 0 40 y
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
4 d early
2024
27 d early
2023
30 d late
2022
59 d late
2021
81 d late
2020
151 d late
2019
61 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€41.25M▲ 8.3%
2024 · €38.10M
2018: €22.46M 2019: €26.42M 2020: €22.58M 2021: €29.61M 2022: €39.19M 2023: €38.07M 2024: €38.10M
2018 → 2025
EBIT margin
38.9%▲ 9.6pp
2024 · 29.2%
2018: 22.0% 2019: 26.1% 2020: 33.2% 2021: 39.5% 2022: 37.9% 2023: 33.2% 2024: 29.2%
2018 → 2025
Net result
€38.07M▼ 56.6%
2024 · €87.80M
2018: €3.39M 2019: €4.76M 2020: €5.36M 2021: €8.82M 2022: €12.07M 2023: €8.55M 2024: €87.80M
2018 → 2025
Working capital
€-69.15M▼ 699%
2024 · €-8.66M
2018: €8.12M 2019: €12.82M 2020: €18.17M 2021: €27.28M 2022: €37.97M 2023: €46.27M 2024: €-8.66M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€29.61M-€39.19M▲ 32.4%€38.07M▼ 2.9%€38.10M▲ 0.1%€41.25M▲ 8.3%
Equity€32.67M-€44.74M▲ 37.0%€53.29M▲ 19.1%€654.84M▲ 1,129%€595.32M▼ 9.1%
Operating result€11.69M-€14.85M▲ 27.0%€12.63M▼ 15.0%€11.14M▼ 11.8%€16.03M▲ 43.9%
Net result€8.82M-€12.07M▲ 36.9%€8.55M▼ 29.2%€87.80M▲ 927%€38.07M▼ 56.6%
Result per fiscal year
Operating resultNet result
€0€25.00M€50.00M€75.00M€100.00MOperating result 2021: €11.69M€11.69MNet result 2021: €8.82M€8.82MOperating result 2022: €14.85M€14.85MNet result 2022: €12.07M€12.07MOperating result 2023: €12.63M€12.63MNet result 2023: €8.55M€8.55MOperating result 2024: €11.14M€11.14MNet result 2024: €87.80M€87.80MOperating result 2025: €16.03M€16.03MNet result 2025: €38.07M€38.07M20212022202320242025€0€25M€50M€75M€100MOperating result 2023: €12.63M€13MNet result 2023: €8.55M€8.6MOperating result 2024: €11.14M€11MNet result 2024: €87.80M€88MOperating result 2025: €16.03M€16MNet result 2025: €38.07M€38M202320242025
The operating result recovers in 2025; 2025 is 44% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €769.00M
Fixed assets €664.79M ▲ 0.2%
Current assets €104.22M ▼ 34.4%
Equity and liabilities €769.00M
Equity €595.32M ▼ 9.1%
Debt €173.68M ▲ 3.6%
Debt's share of the balance-sheet total rises from 20.4% to 22.6%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€17.74M
2024 · €12.75M
Cash flow
€39.78M
2024 · €89.40M
Current ratio
0.60
2024 · 0.95
Quick ratio
0.52
2024 · 0.90
Debt to equity
0.29
2024 · 0.26
ROE
6.4%
2024 · 13.4%
ROA
5.0%
2024 · 10.7%
Interest coverage
1.93
2024 · 2.57
Debt ≤ 1 year
€173.36M
2024 · €167.55M
Income taxes
€2.20M
2024 · €1.86M
Staff costs
€16.43M
2024 · €15.80M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 76 lines
Balance sheet Code20242025
Assets
Total assets20/58€822.46M€769.00M
Fixed assets21/28€663.56M€664.79M
Intangible fixed assets21€1.77M€1.58M
Tangible fixed assets22/27€7.02M€8.43M
Plant, machinery and equipment23€4.03M€4.76M
Furniture and vehicles24€69k€93k
Leasing and similar rights25€113k€113k=
Other tangible fixed assets26€726k€1.26M
Assets under construction and advance payments27€2.08M€2.21M
Financial fixed assets28€654.77M€654.77M=
Affiliated companies280/1€654.77M€654.77M=
Participating interests280€654.77M€654.77M=
Current assets29/58€158.89M€104.22M
Stocks and contracts in progress3€8.32M€14.16M
Contracts in progress37€8.32M€14.16M
Amounts receivable within one year40/41€65.41M€62.01M
Trade receivables40€10.19M€7.75M
Other amounts receivable41€55.21M€54.26M
Cash at bank and in hand54/58€84.94M€27.71M
Deferred charges and accrued income490/1€229k€344k
Equity and liabilities
Total equity and liabilities10/49€822.46M€769.00M
Equity10/15€654.84M€595.32M
Contributions10/11€513.88M€513.88M=
Capital10€348k€348k=
Issued capital100€348k€348k=
Outside capital11€513.53M€513.53M=
Share premium1100/10€513.53M€513.53M=
Reserves13€1.94M€1.94M=
Non-distributable reserves130/1€35k€35k=
Legal reserve130€35k€35k=
Distributable reserves133€1.90M€1.90M=
Profit (loss) carried forward14€139.03M€79.51M
Amounts payable17/49€167.61M€173.68M
Amounts payable within one year42/48€167.55M€173.36M
Financial debts43€160.75M€166.54M
Other loans439€160.75M€166.54M
Trade debts44€1.18M€1.40M
Suppliers440/4€1.18M€1.40M
Advances received on contracts in progress46€2.27M-
Taxes, remuneration and social security45€3.35M€5.42M
Taxes450/3-€1.28M
Remuneration and social security454/9€3.35M€4.13M
Accrued charges and deferred income492/3€63k€320k
Income statement Code20242025
Operating income70/76A€39.31M€47.09M
Turnover70€38.10M€41.25M
Change in stocks of work in progress, finished goods and contracts in progress71€1.20M€5.84M
Non-recurring operating income76A€16k€3k
Operating charges60/66A€28.17M€31.06M
Goods for resale, raw materials and consumables60€3.90M€3.94M
Purchases600/8€3.90M€3.94M
Services and other goods61€6.57M€8.45M
Remuneration, social security and pensions62€15.80M€16.43M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.61M€1.71M
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€169k€177k
Other operating charges640/8€122k€355k
Operating profit (loss)9901€11.14M€16.03M
Financial income75/76B€83.58M€36.50M
Recurring financial income75€83.58M€36.50M
Income from financial fixed assets750€83.07M€32.93M
Other financial income752/9€513k€3.57M
Financial charges65/66B€5.06M€12.26M
Recurring financial charges65€5.06M€12.26M
Debt charges650€4.95M€9.20M
Other financial charges652/9€111k€3.06M
Profit (loss) for the period before taxes9903€89.66M€40.27M
Income taxes67/77€1.86M€2.20M
Taxes670/3€1.86M€2.20M
Profit (loss) for the period9904€87.80M€38.07M
Profit (loss) for the period to be appropriated9905€87.80M€38.07M
Appropriation of the result
Profit (loss) to be appropriated9906€139.05M€177.10M
Profit (loss) brought forward from the previous period14P€51.25M€139.03M
Transfer to equity691/2€22k-
To the legal reserve6920€22k-
Profit to be distributed694/7-€97.59M
Return on contributions (dividend)694-€97.59M
Social balance
Average headcount (FTE)9087175.4202.5

The notes to these accounts (57 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
10-08
State Gazette act Resignations: GARA (director) and Riaz Amirali BANDALI (director)
Appointments: GARA (director) and Riaz Amirali BANDALI (director) · Permanent representative: Kurt Marcel Ursula PEETERS · Legal-form conversion13 facts ▸
  • General meeting, 23-07-2026
  • Legal-form conversion, Naamloze vennootschap -> Besloten vennootschap
  • Net-asset statement, 31-05-2026
  • Director resignation, GARA (director)
  • Director resignation, Riaz Amirali BANDALI (director)
  • Director appointment, GARA (director)
  • Director appointment, Riaz Amirali BANDALI (director)
  • Permanent representative, Kurt Marcel Ursula PEETERS
  • Mandate compensation, GARA
  • Mandate compensation, Riaz Amirali BANDALI
  • Power of attorney, BERQUIN NOTARISSEN
  • Shares issued, 278
  • +1 further facts in this act
04-08
State Gazette act Resignation: Joseph Shrawder (director)
Appointment: Riaz Amirali Bandali (director) · Power of attorney7 facts ▸
  • General meeting, 30/06/2026
  • Director resignation, Joseph Shrawder (director)
  • Director appointment, Riaz Amirali Bandali (director)
  • Power of attorney, Susana Gonzalez Melon
  • Power of attorney, Hannelore De Bie
  • Power of attorney, Dries Remeysen
  • Power of attorney, Allen Overy Shearman Sterling (Belgium) LLP
27-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
04-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Highest result since 2018net €87.80M ▲927%
Net result €87.80M, the highest in the series.
31-12
Financial Equity above €500MEq €654.84M ▲1129%
7 profitable years in a row build equity to €654.84M.
30-08
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 30 days late
2023
31-12
Financial Equity above €50MEq €53.29M ▲19.1%
6 profitable years in a row build equity to €53.29M.
28-09
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 59 days late
2022
20-10
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 81 days late
2021
31-12
Financial Equity above €25MEq €32.67M ▲37%
4 profitable years in a row build equity to €32.67M.
29-12
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 151 days late
Show earlier events
2020
30-09
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 61 days late
2019
08-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
14-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
14-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 directors, no change since 2026
GARA
Director · since 23-07-2026 · Private limited company · perm. rep.: Kurt Marcel Ursula PEETERS
Current
Riaz Amirali BANDALI
Director · since 23-07-2026
Current
23-07-2026 GARA: Reappointed as Director
23-07-2026 Riaz Amirali BANDALI: Reappointed as Director
30-06-2026 Riaz Amirali BANDALI: Appointed as Director
30-06-2026 Joseph Shrawder: Resigned as Director
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 1991
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Romeinse straat 123001 Leuven
Ground area
1.0 ha
Building footprint
1,691 m²
Volume, LiDAR
19,452 m³
Parcel 24514C0093/00W000, Flanders · tallest building 13.7 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
TOXIKON EUROPE NV
Romeinse straat 12, 3001 LeuvenNACE 7412401
since 19912.051.016.696
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24514C0093/00W000 Flanders 1.0 ha 1 · 1,691 m² 13.7 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Articles of association

Purpose
De vennootschap heeft tot voorwerp in België en in het buitenland multidisciplinaire toxicologische en milieu- onderzoekingen en testen te verrichten, gericht op de evaluatie van…
Full purpose

De vennootschap heeft tot voorwerp in België en in het buitenland multidisciplinaire toxicologische en milieu- onderzoekingen en testen te verrichten, gericht op de evaluatie van de effecten van producten en procedés op de menselijke gezondheid en op het milieu. De vennootschap zal daartoe de nodige laboratoria, studiecentra en kantoren organiseren, oprichten en betrekken. De vennootschap zal analyses maken, adviesactiviteiten ontwikkelen en rapporten leveren aan milieu-ingenieurs en aan de industrie en zich in het bijzonder bezighouden met scheikunde, ecotoxicologie, zoogdieren-toxicologie, in- vitro en alternatieve toxicologie, genetische, water- en luchttoxicologie. Deze activiteiten zullen omvatten, doch niet beperkt zijn tot 1. water- en luchttoxicologie 2. effectenrapportering 3. bioremediatie 4. wetenschappelijk onderzoek op het gebied van pesticide-, herbicide- en insecticideregistraties 5. wetenschappelijke en technische raadgevingen 6. biomedisch onderzoek en -ontwikkeling 7. in—vivo en in-vitro toxicologie. De vennootschap mag alle vormen van toegepast wetenschappelijk onderzoek doen van nieuwe procedés of nieuwe producten, evenals alle brevetten, merken, licenties, tekeningen en modellen, op punt stellen en commercialiseren. De vennootschap mag ook zelf licenties nemen. De vennootschap mag, in het algemeen, alle mogelijke commerciële, industriële, financiële, roerende of onroerende operaties doorvoeren, die direct of indirect verband houden met haar voorwerp of die van aard zouden zijn de verwezenlijking ervan te vergemakkelijken of te bevorderen. Zij kan zich door alle middelen inmengen in alle zaken, ondernemingen of vennootschappen die eenzelfde, gelijkaardig of aanverwant voorwerp hebben of die van aard zijn om de ontwikkeling van haar onderneming te bevorderen. De vennootschap mag eveneens aandelen hebben in een andere vennootschap, mag als raadgever optreden met betrekking tot dezelfde, gelijkaardig of aanverwante zaken en mag tussenkomen in het management. De Organisatie en de coördinatie van elke andere vennootschap die eenzelfde, analoog, gelijkaardig of aanverwant voorwerp hebben, zowel in België als in het buitenland. De vennootschap kan haar activiteiten hetzij voor eigen rekening, hetzij bij deelname met derden, hetzij voor rekening van derden verrichten. De vennootschap mag, door middel van inbreng, fusie, onderschrijving of elke andere wijzen inmengen in alle ondernemingen, verenigingen of vennootschappen die eenzelfde, gelijkaardig of aanverwant voorwerp hebben of die van aard zijn om de ontwikkeling van haar activiteit te bevorderen. De vennootschap mag haar voorwerp realiseren op om het even welke plaats, op om het even welke manier en met die middelen die haar het meest geschikt lijken.

Structure & network

Public money · subsidies and aid

Flemish government

2022 to 2025 · 5 entries · 29,906 EUR awarded · 29,906 EUR paid
Year Entries awardedpaid
2025 2 7,002 EUR7,002 EUR
2024 1 7,562 EUR7,562 EUR
2023 1 8,739 EUR8,739 EUR
2022 1 6,603 EUR6,603 EUR
Schemes
Vlaams opleidingsverlof (VOV)
4 entries · 25,313 EUR · 25,313 EUR paid · Departement Werk en Sociale Economie
Individueel Maatwerk
1 entry · 4,593 EUR · 4,593 EUR paid · Departement Werk, Economie, Wetenschap, Innovatie en Sociale Economie

Recognitions · licences · registrations

Legal Entity Identifier

894500R99IWJHGVJWP70
live in the LEI register

Similar companies · same sector, comparable size

Of 1,177 companies in sector 72109 we hold annual accounts for 715. 20 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded28-12-1990
Fiscal year end31-12
Activities, NACEBEL 2025
71121Engineering and related technical consultancy, excluding land surveyors
72109Other research and development on natural sciences
Sources
Crossroads Bank for EnterprisesNational Bank · 35 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.